HRT Financial’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-444,767
Closed -$631K 3479
2022
Q4
$631K Buy
+444,767
New +$954K 0.01% 1263
2022
Q3
Sell
-140,043
Closed -$317K 3755
2022
Q2
$317K Buy
+140,043
New +$522K ﹤0.01% 1979
2021
Q4
Sell
-94,026
Closed -$950K 4356
2021
Q3
$950K Buy
+94,026
New +$1.03M 0.01% 1376
2020
Q4
Sell
-47,519
Closed -$363K 2658
2020
Q3
$363K Buy
+47,519
New +$349K 0.01% 1036
2020
Q1
Sell
-16,603
Closed -$175K 1486
2019
Q4
$175K Buy
+16,603
New +$147K 0.01% 970

Other funds holding DBD

HRT Financial's DBD Position: Q1 2023 in Review

HRT Financial sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 444,767 shares — an estimated $631K sold.

HRT Financial first reported a position in DBD in Q4 2019 and held it in 5 quarters. The position peaked at $950K in Q3 2021. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • HRT Financial reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 444,767 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $631K.
  • HRT Financial first reported a position in Diebold Nixdorf Incorporated in Q4 2019 and held it in 5 quarters.
  • HRT Financial's Diebold Nixdorf Incorporated position peaked at $950K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.